Eurofins Scientific

Eurofins Scientific is an international life sciences company operating in food & pharmaceutical products testings. Co. provides analytical testing services to clients from various industries including pharmaceutical, food, and environmental sectors. Co. offers analytical methods for evaluating the authenticity, origin, safety, identity, composition, and purity of biological substances & products. Co. verifies authenticity of products analyzed to detect dangerous components (pathogens, prions, pesticides, asbestos, mycotoxins, dioxins, toxic substances, etc.). Co. operates in Benelux, France, Germany, North America, Scandinavia, British Isles (U.K. & Republic of Ireland), & other countries.
  • TickerERF
  • ISINFR0000038259
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

GlobalData Department

Eurofins Scientific SE (ERF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, ide...

Jérôme VINERIER

Analyse court terme - EUROFINS SCIENTIFIC : La reprise est une consolidation.

La tendance est baissière. La reprise est une consolidation. Les Stochastiques sont en zone de surachat. La baisse peut bientôt reprendre vers 399,00 €. La tendance de fond serait remise en cause en cas de franchissement de 492,30 €.

Jérôme VINERIER

Short term view - EUROFINS SCIENTIFIC : The recovery is a consolidation.

The trend is bearish. The recovery is a consolidation. Stochastics are at the overbought level. The fall can soon resume toward €399.00. The background trend would be questioned should prices rise above €492.30.

Ahmed Ben Salem ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Igor Kim
  • Jean Sassus
  • Jean-Baptiste Rouphael
  • Martial Descoutures
  • Pierre Corby
  • Roland Pfaender
  • Steven Gould
  • Valentin Pernet
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/01/2018

...

Ahmed Ben Salem ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Igor Kim
  • Jean Sassus
  • Jean-Baptiste Rouphael
  • Martial Descoutures
  • Pierre Corby
  • Roland Pfaender
  • Steven Gould
  • Valentin Pernet
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 01/11/2018

...

Maxime Kogge

Eurofins : A perpetual bond to restore deteriorated credit metrics after M&A frenzy

Eurofins launched a new perpetual bond issue of € 300m, complementing the capital increase performed on Monday for the same amount. The group is closing the financing of its intense acquisition drive in recent months, enabling it to maintain its long-term net leverage target of below 2.5x. The roadshows will end today with a meeting in Paris at 12.30 p.m. CET. - >Together with the capital increase, the bond issue limits the impact of recent acquisitions on leverage. The structuring paves the way for a public rating - The documentation includes an innovation compared with the two existing ...

Maxime Kogge

Eurofins : Une perpétuelle qui restaure des ratios dégradés par la frénésie de M&A

Eurofins a lancé l’émission d’une nouvelle obligation perpétuelle de 300 m EUR en complément de l’augmentation de capital du même montant réalisée lundi. Le groupe de laboratoires boucle ainsi le financement de sa croissance externe intense des derniers mois et il revient sous un levier net de 2.5x, son objectif long-terme. Les roadshows se terminent aujourd’hui par un meeting à Paris à 12h30. - >Combinée à l’augmentation de capital, l’émission limite l’impact des acquisitions récentes sur le levier. La structuration ouvre la voie à une notation publique - La documentation inclut une inno...

Christophe-Raphaël Ganet

Eurofins : Acquisition in Canada (C$30m) - build-up continues

>Acquisition in the environmental sector - Erofins announced yesterday evening the acquisition of EnvironeX (C$ 30m – 275 employees – 3 laboratories).EnvironeX specialises in environmental, agri-food and pharmaceutical analyses. Its customers are local authorities, construction groups and consultants in environmental, agri-food and pharmaceutical analyses.Strengthened leadership in the environment segment in North America and nearly $ 530 in acq...

Christophe-Raphaël Ganet

Eurofins : Acquisition au Canada USA (30 MCAD.) – Poursuite du build-up

>Acquisition dans le domaine de l’environnement - Eurofins a annoncé hier soir l’acquisition de EnvironeX (30 MCAD – 275 pers. – 3 laboratoires).EnvironeX est spécialisé dans les analyses environnementales, agroalimentaires et pharmaceutiques. Ses clients sont des collectivités locales, des groupes de BTP ou des consultants en analyses environnementales, agroalimentaires et pharmaceutiques.Leadership conforté en Environnement en Amérique du Nord...

Alexandre Iatrides ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emira Sagaama
  • Fehmi Ben Naamane
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Léopold Authié
  • Matthias Desmarais
  • Nicolas David
  • Rémi Adam
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Veysel Taze
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 24/10/2018

La récente faiblesse du titre offre un bon point d’entrée pour prendre l’histoire en marche et jouer ce profil différenciant (consumer, premium) qui devrait permettre à Pirelli d’afficher l’une des croissances les plus élevées du secteur d’ici 2021 (TMVA BPA de 18%). Nous initions la valeur avec une opinion Achat et un objectif de cours de 7.2 €. Cf étude publiée. - ...

Alexandre Iatrides ...
  • Alfred Glaser
  • Antoine Boivin-Champeaux
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emira Sagaama
  • Fehmi Ben Naamane
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Léopold Authié
  • Matthias Desmarais
  • Nicolas David
  • Rémi Adam
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Veysel Taze
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/24/2018

The share’s recent weakness offers a good entry point to buy into the story and play Pirelli’s differentiating profile (consumer, premium), which should enable it to post one of the highest growth rates in the sector out to 2021 (EPS CAGR of 18%). We are initiating coverage with a Buy recommendation and target price of € 7.2. Cf report published. - - ...

Christophe-Raphaël Ganet

Eurofins : Feedback conf call T3 : vers la fin des mega deals ?

>Message du CEO : vers moins d'acquisitions et plus de cash-flow - Le CEO a tenu sa conférence téléphonique trimestrielle hier soir.De sa présentation, nous retenons plusieurs points intéressants :1- s'il juge la croissance (publiée et organique) "bonne", il indique aussi que le rythme d'acquisitions de ces dernières années a été exceptionnel (700 M€ de CA acquis en 2018, après 700 M€ en 2017, 220 M€ en 2016 et 570 M€ en 2015), donc non extrapolable: "peu po...

Ahmed Ben Salem ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Igor Kim
  • Jean Sassus
  • Jean-Baptiste Rouphael
  • Martial Descoutures
  • Pierre Corby
  • Roland Pfaender
  • Steven Gould
  • Valentin Pernet
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/01/2018

...

Ahmed Ben Salem ...
  • Antoine Boivin-Champeaux
  • Christophe-Raphaël Ganet
  • Igor Kim
  • Jean Sassus
  • Jean-Baptiste Rouphael
  • Martial Descoutures
  • Pierre Corby
  • Roland Pfaender
  • Steven Gould
  • Valentin Pernet
  • Yan Derocles
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 01/11/2018

...

Alex Koagne ...
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Jean Sassus
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 10/15/2018

...

Ahmed Ben Salem ...
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Jean Sassus
  • Laure Billoret
  • Matthias Desmarais
  • Steven Gould
  • Valentin Pernet
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/15/2018

...

Ahmed Ben Salem ...
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Jean Sassus
  • Laure Billoret
  • Matthias Desmarais
  • Steven Gould
  • Valentin Pernet
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 15/10/2018

...

An unfavourable environment weighs on EUROFINS SCIENTIFIC AG, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of EUROFINS SCIENTIFIC AG (FR), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date October 9, 2018, the closing price was EUR 428.80 and its target price was estimated at EUR 407.18.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

GlobalData Department

Eurofins Scientific SE (ERF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, ide...

Charles Pinel

Proxy Report - 26/04/2018

Each year the company publishes the amount of the remuneration due to the executive directors but does not publish any information on the remuneration policy. In addition, the company does not submit any resolution that allows shareholders to approve. Therefore, we will recommend opposition of resolution 7 on the discharge for directors, even if this is a mandatory resolution in Luxembourg. The company proposes two resolution on the renewal of directors. We will support Patrizia Luchetta and Fereshteh Pouchantchi as Directors - both of them are free from conflicts of interest (resolutions 9 ...

Charles Pinel

Proxy Report - 26/04/2018

Comme chaque année, la société fournit les montants des rémunérations des dirigeants mais très peu d'information sur la politique de rémunération. De plus, elle ne soumet pas de résolutions permettant aux actionnaires de se prononcer sur ce sujet. Par conséquent, notre réserve s'exprimera par une recommandation négative sur la demande de quitus en faveur des administrateurs qui est une résolution obligatoire au Luxembourg (résolution 7). Deux renouvellements d’administrateurs sont soumis au vote. Nous soutiendrons la candidature de Patrizia Luchetta ainsi que de Fereshteh Pouchantchi, toutes ...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

Jérôme VINERIER

Analyse court terme - EUROFINS SCIENTIFIC : La reprise est une consolidation.

La tendance est baissière. La reprise est une consolidation. Les Stochastiques sont en zone de surachat. La baisse peut bientôt reprendre vers 399,00 €. La tendance de fond serait remise en cause en cas de franchissement de 492,30 €.

Jérôme VINERIER

Short term view - EUROFINS SCIENTIFIC : The recovery is a consolidation.

The trend is bearish. The recovery is a consolidation. Stochastics are at the overbought level. The fall can soon resume toward €399.00. The background trend would be questioned should prices rise above €492.30.

Jérôme VINERIER

Short term view - EUROFINS SCIENTIFIC : The trend is bearish.

The trend is bearish. The recovery is a consolidation. The fall might resume toward €399.00. The background trend would be questioned should prices rise above €492.30.

Jérôme VINERIER

Analyse court terme - EUROFINS SCIENTIFIC : La tendance est baissière.

La tendance est baissière. La reprise est une consolidation. La baisse risque de reprendre jusqu'à 399,00 €. La tendance de fond serait remise en cause en cas de franchissement de 492,30 €.

Jérôme VINERIER

Medium term view - EUROFINS SCIENTIFIC : The trend is uncertain.

The trend is uncertain. Prices are falling and they may accelerate to the downside. A new bearish trend is attempting to emerge.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch